Occurrence and Time-To-Onset of Cytomegalovirus Infection in Patients Treated with First- and Second-Generation Bruton’s Tyrosine Kinase Inhibitors: A Retrospective Analysis of Data from The Japanese Adverse Drug Event Report Database
Journal of Pharmacy and Pharmacology Research · 2026
DOI: 10.26502/fjppr.0130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology Research, 2026. Verfasst von Kaori Ito und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ito, K., Kato, K., Morisaku, M., Yamada, S., & Hayakawa, N. (2026). Occurrence and Time-To-Onset of Cytomegalovirus Infection in Patients Treated with First- and Second-Generation Bruton’s Tyrosine Kinase Inhibitors: A Retrospective Analysis of Data from The Japanese Adverse Drug Event Report Database. Journal of Pharmacy and Pharmacology Research. https://doi.org/10.26502/fjppr.0130
Vancouver
Ito K, Kato K, Morisaku M, Yamada S, Hayakawa N. Occurrence and Time-To-Onset of Cytomegalovirus Infection in Patients Treated with First- and Second-Generation Bruton’s Tyrosine Kinase Inhibitors: A Retrospective Analysis of Data from The Japanese Adverse Drug Event Report Database. Journal of Pharmacy and Pharmacology Research. 2026. doi:10.26502/fjppr.0130
BibTeX
@article{Ito2026,
author = {Ito, Kaori and Kato, Koki and Morisaku, Misaki and Yamada, Shigeki and Hayakawa, Nobuki},
title = {Occurrence and Time-To-Onset of Cytomegalovirus Infection in Patients Treated with First- and Second-Generation Bruton’s Tyrosine Kinase Inhibitors: A Retrospective Analysis of Data from The Japanese Adverse Drug Event Report Database},
journal = {Journal of Pharmacy and Pharmacology Research},
year = {2026},
doi = {10.26502/fjppr.0130}
}
EUVIMED